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CLINICAL RESEARCH ARTICLE
Feasibility of narrative exposure therapy in an outpatient day treatment
programme for refugees: improvement in symptoms and global functioning
Simone M. de la Riea, Geert E. Smid a,b, Niels van der Aaa, Leanne A. C. van Estc,d, Eef Bisselinga
and Paul A. Boelen a,c
aARQ National Psychotrauma Centre, ARQ Centrum’45, Diemen, The Netherlands; bUniversity of Humanistic Studies, Utrecht, The
Netherlands; cDepartment of Clinical Psychology, Faculty of Social Sciences, Utrecht University, Utrecht, The Netherlands; dReinier van
Arkel, Psychotraumacentrum Zuid Nederland, ’s Hertogenbosch, The Netherlands
ABSTRACT
Background: Refugees are at high risk for developing post-traumatic stress disorder (PTSD).
Narrative exposure therapy (NET) is an evidence-based treatment of PTSD, designed for
patients exposed to (multiple) traumatic events and recommended for patients with
culturally diverse backgrounds. In clinical practice, adherence to the NET-protocol has been
challenged because of psychosocial complexities and comorbid disorders.
Objective: The current study investigated the feasibility of NET embedded in an outpatient
day treatment programme for refugees and examined reduction in PTSD symptoms and
improvement of global functioning as well as correlates of change.
Method: Participants were patients who consecutively entered an outpatient daytreatment
programme from 2013-2017. The majority had a history of prior unsuccessful treatment.
PTSD was assessed with the Clinically Administered PTSD Scale (CAPS) before and after
finishing NET. Global Assessment of Functioning (GAF) was used to examine changes in
functioning. Changes in PTSD scores and functioning were analyzed using paired t-tests and
reliable change indices. Patients showing significant improvement were compared to those
who did not, on patient and treatment characteristics, including sex, age, region of origin,
childhood trauma and treatment duration and dosage of NET.
Results: Of 97 patients, 76 (78.4%) completed NET. Completers had a longer residency and
were more likely to have a partner. Significant reductions in PTSD symptoms and improve-
ments in global functioning were observed. Twenty-eight percent showed reliable improve-
ment with large effect sizes. Four patients did no longer meet the criteria for PTSD. No
strong moderators for changes were found. Patients who did not improve more often had a
history of childhood trauma.
Conclusions: NET embedded in an outpatient day treatment programme appears to be
feasible. In those who improved, a substantial decline in symptoms and improvement of
functioning were observed. The findings suggest that a socially supportive living environ-
ment enhances acceptability of trauma-focused treatment in refugees.
Factibilidad de la terapia de exposición narrativa en un programa de
tratamiento diurno ambulatorio para refugiados: mejoría en síntomas
y funcionamiento global
Antecedentes: Los refugiados están en alto riesgo de desarrollar trastorno de estrés
postraumático (TEPT). La terapia de exposición narrativa (NET) es un tratamiento basado
en evidencia del TEPT, diseñado para pacientes expuestos a eventos traumáticos (múltiples)
y recomendado para pacientes con antecedentes culturalmente diversos. En la práctica
clínica, la adherencia al protocolo NET ha sido desafiada debido a las complejidades
psicosociales y los trastornos comórbidos.
Objetivo: El estudio actual investigó la factibilidad de NET incluido en un programa de
tratamiento diurno ambulatorio para refugiados y examinó la reducción de síntomas de
TEPT y la mejora del funcionamiento global, así como correlatos de cambio.
Método: Los participantes fueron pacientes que ingresaron consecutivamente a un pro-
grama de tratamiento diurno ambulatorio entre 2013–2017. La mayoría tenía antecedentes
de tratamiento previo sin éxito. El TEPT se evaluó con la Escala de TEPT administrada
clínicamente (CAPS, por sus siglas en ingles) antes y después de finalizar NET. La
Evaluación Global del Funcionamiento (GAF) se utilizó para examinar los cambios en el
funcionamiento. Los cambios en los puntajes y el funcionamiento del TEPT se analizaron
mediante t-test pareados e índices de cambio confiables. Los pacientes que mostraron una
mejoría significativa fueron comparados con aquellos que no lo hicieron, en cuanto a las
características del paciente y tratamiento, incluidos sexo, edad, región de origen, trauma
infantil y duración del tratamiento, y dosificación de NET.
Resultados: De 97 pacientes, 76 (78.4%) completaron NET. Los que completaron tenían un
periodo de residencia más largo y tenían más probabilidades de tener una pareja. Se
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HIGHLIGHTS
• NET embedded in an
outpatient day treatment
programme is feasible and
facilitates the chance of
completion of trauma-
focused therapy, even in
patients with a history of
unsuccessful treatment.
• A substantial decline in
symptoms and better
functioning was observed in
those improved.
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observaron reducciones significativas en los síntomas de TEPT y mejoras en el funciona-
miento global. Veintiocho por ciento mostró una mejora confiable con grandes tamaños de
efecto. Cuatro pacientes ya no cumplían los criterios para TEPT. No se encontraron fuertes
moderadores para los cambios. Los pacientes que no mejoraron con mayor frecuencia
tenían antecedentes de trauma infantil.
Conclusiones: NET integrado en un programa de tratamiento ambulatorio diurno se mues-
tra factible. En aquellos que mejoraron, se observó disminución sustancial de los síntomas
y una mejoria del funcionamiento. Los hallazgos sugieren que un entorno de vida de apoyo
social aumenta la aceptabilidad del tratamiento centrado en el trauma en los refugiados.
难民的门诊日间治疗计划中叙事暴露疗法的可行性：症状和整体功能的
改善
背景: 难民患创伤后应激障碍 (PTSD) 的风险很高。叙事暴露疗法 (NET) 是PTSD的循证治疗,





失败的病史。在完成NET前后, 使用临床用PTSD量表 (CAPS) 对PTSD进行了评估。使用功
能大体评估量表 (GAF) 考查了功能的变化。使用配对t检验和可靠的变化指数分析了PTSD
得分和功能的变化。对表现出显著改善的患者与未表现出显著改善的患者进行患者及治
疗特征上的比较, 包括性别, 年龄, 籍贯, 童年期创伤以及治疗时间和NET剂量。







At the end of 2019, 70.8 million people were forcibly
displaced around the globe as a result of persecution,
conflict, war, violence or/and human rights violations.
Whereas the majority is internally displaced,
25.9 million people are considered refugees and
3.5 million asylum seekers (United Nations High
Commissioners for Refugees [UNHCR], 2019).
Refugees are often sheltered in a neighbouring country,
but some of them seek asylum in Western countries.
Nearly all of them have been exposed to war, have
witnessed or experienced violence, or the loss of loved
ones, and some of them have been victim of
torture. After suffering from adversities in their home-
land, insecurity, starvation, and poverty during the
flight, as well as adjustment stress during resettlement,
refugees and war-affected populations are at high risk
for post-traumatic stress disorder (PTSD) and major
depressive disorder (MDD) (American Psychiatric
Association [APA], 2013). A high prevalence of PTSD
is found in epidemiological studies, with prevalence of
9% PTSD and 5% with MDD (Steel et al., 2009; Fazel,
Wheeler, & Danesh, 2005). Even several years after
resettlement mental disorders tend to be highly preva-
lent (Bogic, Njoku, & Priebe, 2015). The need for ade-
quate psychological treatment for refugees is self-
evident.
A systematic review revealed that psychosocial inter-
ventions in refugees and asylum seekers resettled in high-
income countries were effective in decreasing PTSD
symptoms relative to control groups, and that narrative
exposure therapy (NET) was the best-supported inter-
vention (Nosè et al., 2017). NET is an evidence-based
short-term intervention for PTSD, designed for patients
exposed to complex ormultiple traumatic events
(Schauer, Neuner, & Elbert, 2011). It has been found to
be feasible in a wide range of participants with culturally
diverse backgrounds and cultural settings (Nosè et al.,
2017; Robjant & Fazel, 2010).
Despite the evidence, clinical experience suggests that
psychosocial problems, comorbid mental health pro-
blems, and ongoing current stressors of refugees can
challenge the feasibility of trauma-focused therapy with
severely traumatized refugees. These pressing issues may
prevent clinicians from adhering to the treatment proto-
col and may reduce the chance to complete trauma-
focused therapy. Furthermore, ongoing current stressors
may also be related to the severity of mental health
complaints and prevent patients to complete or benefit
from treatment. Several studies describe the debilitating
impact of postmigration factors and ongoing stressors on
mental health (Chu, Keller, & Rasmussen, 2013;
LeMaster et al., 2018; Schick et al., 2018; Steel, Dunlavy,
Harding, & Theorell, 2017; Tinghög et al., 2017).
Addressing these ongoing stressors would contribute to
better mental health (Miller & Rasmussen, 2017).
In clinical practice, these types of problems are
often addressed in group treatment or a multimodal
setting. In a review on group treatment for PTSD,
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group treatment was found efficacious compared
with no treatment, and combining individual and
group interventions was recommended (Sloan,
Bovin, & Schnurr, 2012). The few studies on multi-
modal approaches in refugees did not yield compel-
ling evidence for their efficacy (Nickerson, Bryant,
Silove, & Steel, 2011). However, in a recent natura-
listic study based on this approach, a decrease of
PTSD complaints and increase of quality of life
were found (Stammel et al., 2017).
We hypothesized that the feasibility of NET would
improve when it would not be offered as a stand-alone
treatment modality but embedded in a multidisciplinary
multimodal day treatment setting. In such
a multidisciplinary setting different types of counselling
and services could be offered ranging from group ther-
apy, psychosocial counselling and social work, to phar-
macotherapy according to the individual needs,
alongside trauma-focused treatment (NET). The clini-
cian providing NET would not have to postpone or
interrupt the trauma-focused therapy when psychosocial
problems could be discussed in a group or with a social
worker of themultidisciplinary team. In such a settingwe
expected that patients would be supported to complete
NET, adherence to the treatment protocol of the NET-
therapists would be facilitated and ongoing stressors
could be dealt with. Then, it would be more likely that
patients actually benefit from NET and the impact of
ongoing stressors would be alleviated. Accordingly, we
developed an outpatient day treatment programme for
refugees using a well-structured three phase-basedmodel
(Cloitre et al., 2012; Herman, 2015; National Institute
for Health and Care Excellence [NICE], 2005).
In the present naturalistic study, we investigated the
feasibility of NET embedded in an outpatient day treat-
ment programme for refugees and examined the changes
of PTSD symptoms and global functioning as well as cor-
relates of change. The feasibility of NETwas examined by
analysing the treatment trajectory of the patients (includ-
ing NET completion, drop out and adherence to the
treatment protocol by the therapists). Furthermore,
changes in symptom severity, diagnoses of PTSD and
global functioning during the treatment were assessed.
Finally, we explored whether improvement in PTSD and
functioning was associated with a number of variables,
including patient characteristics such as sex, age, region
of origin and treatment characteristics, such as treatment
duration and dosage of NET to gain insight in what
factors may moderate symptom changes.
1. Methods
1.1. Participants
Participants (N = 97) were all refugees who entered
the outpatient day treatment programme for PTSD
between January 2013 and February 2017 at our
treatment facility, ARQ Centrum ’45 (C45). C45 is a
Dutchmental health institute specialised in the treatment
of psychopathology associated with trauma and (multi-
ple) loss due to war and organised violence. C45 receives
national referrals of patients, including refugees who
cannot be treated in general mental health care because
of the complexity or severity of their complaints or who
have shown insufficient response to treatment elsewhere.
‘Refugee’ refers to political arrival status of a person who
was exposed to traumatic events in his or her home
country and during the flight, often followed by adverse
life situations.
Some of the refugees entering treatment are torture
survivors. They have been exposed to torture as defined
in article 1 of the United Nations Convention against
Torture and Other Cruel, Inhuman or Degrading
Treatment or Punishment: ‘any act by which severe pain
or suffering, whether physical or mental, is intentionally
inflicted on a person for such purposes as obtaining from
him or a third person information or a confession, punish-
ing him for an act he or a third person has committed or is
suspected of having committed, or intimidating or coercing
him or a third person, or for any reason based on discri-
mination of any kind, when such pain or suffering is
inflicted by or at the instigation of or with the consent or
acquiescence of a public official or other person acting in an
official capacity. It does not include pain or suffering aris-
ing only from, inherent in or incidental to lawful sanctions’
(United Nations General Assembly, 1984).
The outpatient day treatment programme was
offered as a standard modality to all patients after
intake, when they suffered from severe PTSD com-
plaints, multiple trauma, and to those who had
unsuccessful treatment elsewhere or/and had lim-
ited social support. Unsuccessful treatment refers to
treatment that did not bring about any change in
PTSD symptoms or functioning or that had not
been completed. When they were not willing to
participate in the outpatient day treatment pro-
gramme or had insufficient Dutch language profi-
ciency, they were offered individual trauma-focused
treatment or supportive treatment in our outpatient
clinic. Furthermore, patients with acute and active
suicidality, severe manifest psychotic symptoms
and/or severe alcohol or substance dependency
were not eligible for the treatment programme.
Also, refugees whose symptoms were related pri-
marily to the traumatic loss of loved ones were
referred to an outpatient day patient treatment for
traumatic grief (De Heus et al., 2017).
1.2. The outpatient day treatment programme
for refugees
The outpatient day treatment programme for refu-
gees was administered by a multidisciplinary team.
The team consisted of a psychiatrist, a medical
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doctor, two psychiatrists in training, two clinical psy-
chologists, two psychotherapists, three psychologists
in training, two psychomotor therapists, an art thera-
pist, and three social workers. The members of the
team were predominantly native Dutch women, with
an age ranging from approximately 20 to 60 years.
The team included a male psychiatrist, a male clinical
psychologist and two male social workers.
Throughout the years, the team members did not
change, except for the psychiatrists and psychologists
in training of whom several had a non-Western ori-
gin and could speak either Arabic, Farsi/Dari or
Servokroatic.
The group-based outpatient day treatment pro-
gramme comprised of a weekly five-hour pro-
gramme. The programme lasted one year and
consisted of three phases, each phase with a duration
of 4 months. Every 4 months a new group of eight
participants started the programme in phase 1 (see
Figure 1).
Phase 1. The focus of phase 1 was on building
mutual trust and support within the group as well
as gaining control over psychiatric symptoms. This
was obtained by offering different group therapies.
In group psychotherapy, therapists facilitated
a holding environment and focused on getting to
know and learn to trust each other, and on cohe-
sion within the group. Sociotherapy addressed emo-
tion regulation, sleeping patterns and coping skills.
Through art therapy, patients were encouraged in
sharing (positive and negative) experiences and
expressing emotions. Through psychomotor ther-
apy, patients were assisted to gain control over
emotional instability and physical signs of anxiety.
When indicated, medication was prescribed in
accordance with the guidelines for PTSD (NICE,
2005).
Phase 2. The focus of phase 2 was on emotionally and
cognitively processing the traumatic experiences,
through individual NET. During NET, therapist and
patient together develop a narrative of the patient’s life
by identifying the most meaningful (positive and nega-
tive) life events, symbolized by ‘flowers’ and ‘stones’,
respectively. The therapist supports the patient in con-
structing a chronological narrative of his/her whole life,
while encouraging exposure to traumatic experiences.
Exposure to each traumatic event in a chronological
order aims to reconnect fragmented traumatic memories
with the autobiographical memory and in order to
diminish trauma-related complaints (Schauer et al.,
2011). Furthermore, psychomotor group therapy and
art therapy were offered, further supporting coping
with emotions.
Phase 3. The focus of phase 3 was on further integrat-
ing the traumatic experiences in the life history, shifting
attention from the past to the present and making future
plans. In supportive group therapy patients were encour-
aged to discuss future plans and strengthen social net-
works. They were assisted in applying for jobs or
voluntary work and expanding their fields of interest.
In psychomotor therapy emotion regulation skills were
consolidated by exercises.
In each phase, consultations with the psychotherapist,
physician or social worker were offered when needed.
1.3. Procedure
When participants entered the programme, an inven-
tory was made regarding patient characteristics, treat-
ment needs and current stressors at the consultation
Time Phase 1 (4 months) Phase 2 (4 months) Phase 3 (4 months)
10.00 Welcome







13.15 Sociotherapy Psychomotor therapy Consultation hour
14.30 Consultation hour Consultation hour
Group-based, phase 1, 2 & 3 combined
Individual
Group-based, separate for each phase
Figure 1. Outline of the outpatient treatment programme for refugees. The programme consists of three phases having
a 4-month duration.
The first phase focuses on building trust, enhancing understanding of the complaints and improving coping, emotion regulation, and sleeping.
The second phase focuses on processing the traumatic memories. The third phase focuses on personal and societal rehabilitation. Throughout
the entire programme, patients can consult any of the other practitioners (psychiatrist, psychotherapist, social worker, socio-therapist, art
therapist, psychomotor therapist) when needed.
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with an individual therapist. Finally, treatment goals
were formulated. Assessments pre- and post-
treatment were conducted for clinical purposes dur-
ing the programme, in the first month of the day
treatment programme before the start of NET (T1)
and after finishing NET (T2), in general during the
third phase of the programme, by a team of trained
and supervised psychologists/psychologists in train-
ing. The person who carried out the assessment was
not the same person as the individual therapist. The
primary aim of these assessments was providing feed-
back to the therapist regarding progress in a number
of treatment outcomes due to the individual NET.
Assessment data were archived for scientific research
purposes. Participants were informed about the sto-
rage of the assessment data and given the opportunity
to have their data removed from the database. Upon
consultation, the institutional review board of Leiden
University stated that no review of the ethical merits
of this study was needed and obtaining informed
consent was not requisite, because assessments were
conducted primarily for clinical and secondarily for
research purposes.
The protocol was applied in phase 2 of the Day
Treatment Programme in which the sessions were
scheduled every week. In case of no show, the thera-
pist continued NET the following week or scheduled
sessions twice a week to compensate for missed
appointments (of NET). After an interruption of
treatment due to holidays or somatic illness the
therapist read the narrative before the continuation
of the exposure sessions. NET sessions lasted 75 min-
utes on average. NET was offered by trained thera-
pists, and treatment progress was discussed every 6 to
8 weeks in intervision with the NET therapists of the
programme.
Data on treatment characteristics, such as treat-
ment attendance and missed appointments, adher-
ence to the treatment protocol were recorded every
week in the Electronic Patient File (EPF). For NET
completers, i.e. those who did not drop out during
NET, the duration of the individual treatment (in
number of sessions) was registered. Non-completers,
i.e. those who did drop out during NET, were asked
the reasons for drop out by their clinician during
consultations on treatment progress.
Data from the assessments were merged to the
data on treatment attendance, missed appoint-
ments and adherence to the treatment protocol
from the EPF by the data manager of the organi-
zation. Data were subsequently anonymized by
removing and altering information in the data
file such that the data could not directly be traced
to an individual patient by the researchers. Finally,
the anonymized data file was made available to the
researchers.
1.4. Instruments
1.4.1. Clinician-Administered PTSD Scale
The Dutch version of the Clinician-Administered
PTSD Scale (CAPS) for the fourth version of the
Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV; Blake et al., 1995) as well as
the version for DSM-5 (CAPS-5; Boeschoten et al.,
2018; Weathers et al., 2018) were used to assess the
current diagnosis of PTSD and the current severity of
PTSD complaints. The CAPS is a clinician-rated
interview that taps all diagnostic criteria for PTSD
of the DSM. In the first period of data collection, the
CAPS-IV was used. Excellent psychometric properties
across a wide variety of clinical research settings and
trauma populations have been reported for the
CAPS-IV. It is the ‘gold’ standard criterion measure
in the field of psychotrauma because of its convergent
and discriminant validity, diagnostic utility, and sen-
sitivity to clinical change (Weathers, Keane, &
Davidson, 2001). The summed score of frequency
and intensity of symptoms represents overall current
PTSD severity with scores >80 indicating extreme
PTSD (range 0–136). A current PTSD diagnosis was
calculated by using the default F1/I2 rule, whereby
a symptom is considered present if Frequency is rated
1 or higher and Intensity is rated 2 or higher
(Weathers et al., 2017). In the second period of data
collection after the introduction of the DSM-5
(American Psychiatric Association [APA], 2013), the
CAPS-5 was used. Psychometric properties of this
version also have been found to be solid
(Boeschoten et al., 2018; Weathers et al., 2018). It
assesses all DSM-5 criteria of PTSD. A single symp-
tom severity score is rated based on a combination of
frequency and intensity on a 5-point scale ranging
from 0 to 4. By summing the scores of the 20 DSM-5
PTSD symptoms, a total of current PTSD symptom
severity score was computed (range 0–80). According
to the CAPS-5 scoring rule (SEV2 rule), a symptom
or impairment was considered present if its severity is
rated with 2 or higher (Weathers et al., 2018).
A current PTSD diagnosis was established using the
DSM-5 algorithm with the SEV2 rule.
1.5. Global Assessment of Functioning
Global Assessment of Functioning (GAF) was rated
by the patients’ clinician – who was not the NET
therapist – at pre- and post-treatment. The GAF
score ranges from 0 to 100 in line with DSM-IV
and reflects an individual’s occupational, psychologi-
cal, and social functioning on a continuum of mental
health illness. The scores are based on defining char-
acteristics, which include both symptoms and social
functioning (Startup, Jackson, & Bendix, 2002). A
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higher score refers to better functioning. Research
showed that the GAF score proved to be a reliable
measure (Jones, Thornicroft, Coffey, & Dunn,
1995). Although the GAF score was originally
designed as a continuous measure, in clinical practice
it is mostly used as a categorical measure. In addition,
the range of the GAF-scores in the present study was
limited – i.e. the pre- and post-treatment GAF-scores
ranged between 40 and 70. Therefore, the GAF score
was treated as an ordinal measure instead of contin-
uous by dividing the original into 20 ordinal cate-
gories (category 1: GAF score 1–5, category 2: 6–10
etcetera).
1.6. Statistical analysis
Statistical analyses were run in the statistical package
SPSS.
The first step of the evaluation of the feasibility of
the outpatient day treatment programme included
descriptive analysis of treatment characteristics
including completion of NET, duration of NET,
drop-out and adherence to the treatment protocol.
Treatment completers and non-completers were
compared on several characteristics using chi-square
tests and independent sample t-tests. They were com-
pared on the following characteristics: region of ori-
gin (Eastern Europe, the Middle East/Maghreb, Iran–
Afghanistan region, and Niger/Congo), age, sex, hav-
ing a partner (yes or no), type of trauma (torture or
no torture), age of first trauma, type and number of
daily stressors (problems on life domains, including
family relationships, financial problems, work-related
problems or living conditions).
Change of symptoms and global functioning was
examined in those patients who had a complete
assessment pre- and posttreatment. A paired-sample
t-test was used to test whether there was a change in
the mean level of PTSD symptom severity between
the pre- and post-treatment measurement. Cohen’s
d were calculated (Cohen, 1988). In order to obtain
a single pre-treatment (T1) and post-treatment (T2)
score for PTSD symptom severity, the PTSD symp-
tom severity scores of the CAPS-IV and CAPS-5 were
standardized and combined. To make sure that dif-
ferences between T1 and T2 were conserved, standar-
dization of the total PTSD symptom severity scores at
T1 as well as T2 was based on the mean and standard
deviation at T1. The same version of the CAPS was
used at T1 and T2 for 55 out of a total of 56 patients
for whom data on PTSD were available at T1 and T2.
Because no valid comparison can be made between
scores derived from the CAPS-IV and CAPS-5, the
standardized PTSD symptom severity scores, as well
as the diagnosis scores at T1 and T2 were recoded to
missing for one patient who was assessed with the
CAPS-IV at T1 and CAPS-5 at T2. The Wilcoxon
signed-rank test for related samples was used to test
whether there was a change in the median level of the
ordinal GAF score between the pre- and post-
treatment measurement.
Because of the relatively small sample size, an
alternative method of evaluating change in PTSD
symptom severity was also used that does rely on
individual differences rather than means. Individual
changes in PTSD symptom severity were categorized
into recovered, improved, unchanged, and deterio-
rated from T1 to T2 based on criteria of the Reliable
Change Index (RCI) and clinically significant change.
The RCI was used to establish whether the difference
between two test scores obtained at two measurement
occasions reflects statistically reliable change, and was
calculated conform the method described by Jacobson
and Truax (1991), i.e. the ratio between the difference
score between T1 and T2 and the standard error of
the difference score. RCI values larger than 1.96
(or smaller than −1.96) indicate that there is
a statistically reliable difference between two test
scores, i.e. with 95% certainty, the difference between
the test scores is due to actual change (improvement
or deterioration) rather than measurement error.
Clinically significant change was defined as a shift
from a clinical to a subclinical level of PTSD symp-
toms, i.e., respectively, the presence and absence of
a diagnosis of PTSD based on the CAPS. Recovery
can be defined by both a clinically significant change
and a statistically reliable improvement (based on
RCI). Improvement and deterioration can be defined
by a statistically reliable improvement or deteriora-
tion (based on RCI), but no clinically significant
change. Unchanged symptom severity can be defined
by the absence of a statistically reliable change, based
on the RCI. Because the GAF score was an ordinal
measure and no clinical cut-off score has been
defined for it, we based the significant change for
the GAF score on the DSM-IV where the GAF scale
is divided into 10 gradations of global functioning
with 10-point intervals (e.g. GAF score 1–10:
Persistent danger of severely hurting self or others;
GAF score 11–20: Some danger of hurting self or
others). Based on this categorization, clinically signif-
icant change with regard to the GAF score was
assumed when there was a difference of at least 10
points (i.e. 2 categories on the constructed ordinal
measure) between T1 and T2.
The group of patients who recovered or improved
regarding PTSD complaints and on global functioning
and the group of patients who did not were compared
on patient and treatment characteristics again
using chi-square and independent samples t-tests to
gain insight in who is able to benefit from this type of
treatment and who is not. Patient characteristics were
region of origin, age, sex, having a partner, type of
trauma (torture survivor or not), age of first trauma,
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type and number of current stressors (problems on
several life domains, including family, relationship,
financial, work or living conditions). Treatment char-
acteristics were history of prior treatment (yes/no),
length or duration of NET (number of sessions), and
number of minutes of NET.
2. Results
2.1. Patient characteristics
Ninety-seven patients started the treatment during the
study period. Most participants were men
(N = 75; females N = 22) with an average age of 45.5
(SD = 8.5, range 25–62) years. The participants origi-
nated mainly from Eastern Europe (N = 38), the
Middle East/Maghreb (N = 32), Iran–Afghanistan
region (N = 21), and Niger/Congo (N = 5). The educa-
tional level varied from no education/primary school
(N = 16), secondary education (N = 48) to high educa-
tion (N = 31). Sixty participants had a partner (61.9%).
The average stay in the Netherlands before entering
treatment at C45 was 17 years (SD = 6.5, range
3–35 years). The vast majority had obtained a (perma-
nent) residency permit or Dutch citizenship. All
patients suffered from cumulative trauma in the past
and were affected by war violence experiencing or
witnessing, i.e. violence, abuse, or/and loss. Thirty-
three (34.4%) experienced trauma before the age
of 12. This could encompass domestic violence, sexual
abuse or war-related trauma. Twenty-eight
(28.9%) patients were torture survivors. The majority
of the participants reported ongoing stressors in their
current life; 84.5% reported somatic comorbidity, 66%
reported family problems, 54.2% reported work pro-
blems, i.e. unemployment, conflicts at work, 49% suf-
fered from financial problems, i.e. debts, insufficient
income, and 22.7% reported problems with the living
conditions, i.e. poor housing; 64.6% reported three or
more current stressors. Eighty-three patients (85%)
entering treatment in our programme were patients
with prior unsuccessful treatment elsewhere. Two
thirds of those with an unsuccessful treatment history
had been offered another form of trauma-focused ther-
apy, such as EMDR. In Table 1, the patient character-
istics are summarized.
2.2. The feasibility of NET
The majority of the 97 patients were able to complete
NET (N = 76; 78.4%); 61 patients (80.2%) completed
NET within the outpatient day treatment pro-
gramme, whereas 15 patients continued individual
NET in our outpatient clinic after the end of the
treatment programme (i.e. after ending phase 3).
The average duration of the NET of the completers
was 12.5 sessions (SD = 6.6). Sessions were scheduled
as planned weekly and occasionally twice a week to
compensate for missed appointments. Session dura-
tion was 75 minutes. The average dose of NET was
965 minutes (SD = 412). Adherence to the treatment
protocol of the NET therapists when applying NET
was sufficient. Seventy-eight percent of the therapists
were able to focus on the NET protocol and did not
spend more than 2 sessions on other issues (90% no
more than 3 sessions). In those patients who were not
able to complete NET within the outpatient day treat-
ment programme, but continued individual NET in
our outpatient clinic, the duration of therapy was
extended because the NET was interrupted at several
occasions, often related to absence because of somatic
illness, holidays and current stressors.
Drop out of patients occurred at several moments
during the programme. Three patients left the pro-
gramme during phase 1, 13 during phase 2 and 4
patients dropped out from outpatient treatment. The




Gender Male 75 (77.3)
Female 22 (22.7)
Age 45.5 (8.5)




































EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY 7
reasons for drop-out varied and sometimes patients
mentioned more than one reason. Eight patients of all
20 patients who did not complete NETmentioned
that they were unable to complete treatment because
of the difficulties to deal with the emotions provoked
by the confrontation with the traumatic memories
during NET or felt the group setting was too
demanding. They were offered stabilization interven-
tions as an alternative treatment in an individual
trajectory. Other patients who dropped out men-
tioned reasons related to current stressors, including
somatic illness, practical, familial or financial pro-
blems (travel expenses to the institution).
Completers and non-completers were compared
with chi-square analyses and independent samples
t-tests on patient characteristics and treatment charac-
teristics. Only a few significant differences were found
between NET completers and non-completers. The
average residence in the Netherlands was significantly
longer for the completers (M = 18.1, SD = 5.8) in com-
parison to non-completers (M = 13,5, SD = 7.3,
t (85) = −2.9, p < 0.01), and completers were also
more likely to have a partner (χ2(1) = 4.9, p < 0.05).
Non-completers reported more often problems with
their living condition (housing) as a current stressor
than non-completers (χ2(1) = 4.2, p < 0.05), but did
not report significantly more current stressors than
completers.
2.3. Changes in PTSD symptoms during
treatment
Only participants with a complete pre- and post-
treatment assessment of the CAPS of the
outpatient day treatment programme were included in
the analysis (N = 55 for the CAPS). No differences were
found between patients with a complete assessment and
those without on patient characteristics. The mean
scores of PTSD symptoms on CAPS-IV and CAPS-5
are summarized in Table 2. The mean PTSD scores of
the patients’ pre-treatment indicated a high symptom
severity, which can be categorized as ‘extreme PTSD’
and ‘severe PTSD’ according to the standards of
Weathers et al. (2001); Weathers et al. (2018).
A significant decrease in standardized CAPS scores
was found from pre- to post-treatment (t(54) = 5.43,
p < 0.001). Paired samples t-test for the CAPS
resulted in a large effect size (Cohen’s d was 0.78).
Table 3 shows the results of the analysis on the
combined CAPS z-scores. As indicated by the RCIs,
13 (23.7%) patients reported improvement with
regard to PTSD symptoms and four patients (7%)
showed full remission of PTSD; 38 (69%) reported
no change with regard to PTSD symptoms. No
patients deteriorated. We demonstrate in Figure 2
that those classified as recovered or improved accord-
ing to the RCIs substantially declined in PTSD symp-
tom severity by approximately 2 to 3 standard
deviations.
Differences between those who improved and those
who remained unchanged on PTSD symptom severity
were compared by means of chi-square or indepen-
dent samples t-test analyses with regard to patient
characteristics and treatment characteristics. Results
showed that those who did not improve on PTSD
were more likely to have been exposed to a trauma
before the age of 12 (χ2 (1) = 6.42, p < 0.05). Those in
remission differed in terms of background, age, sex
and region of origin.
2.4. Changes in global functioning during
treatment
Only participants with a complete pre- and post-
treatment assessment on global functioning were
included in the analysis (65 on the GAF). Table 4
Table 3. Changes of symptoms on CAPS combined scores
(z-scores) and RCI with regard to PTSD.
RCI N % T1 Mean (SD) T2 Mean (SD) Cohen’s d
Total group 55 100.0 0.00 (0,95) −0.83 (1.16) 0.78
Recovered 4 7.3 0.15 (0.71) −2.99 (1.12)
Improved 13 23.6 0.54 (0.59) −1.32 (0.53)
Unchanged 38 69.1 −0.21 (1.02) −0.43 (1.01)
Deteriorate 0 0.0
CAPS = Clinician-Administered PTSD Scale; PTSD = Posttraumatic Stress
Disorder; RCI = Reliable Change index.
Table 2. PTSD symptoms of CAPS-IV and CAPS-5.
PTSD N T1 Mean (SD) T2 Mean (SD)
CAPS-IV 22 85.5 (13.7) 71.9 (17.4)
CAPS-5 33 46.3 (9.1) 39.00 (10.9)
PTSD = Posttraumatic Stress Disorder;
CAPS-IV = Clinician-Administered PTSD Scale IV;








T1 Mean T2 Mean
Total group Recovered
Improved Unchanged
Figure 2. Change of PTSD in CAPS combined z-scores (y-axis)
from T1 to T2 (x-axis).
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shows the results of the analysis of the GAF scores.
A significant increase in GAF scores was found from
pre- to post-treatment (standardized test statistic = 5.30,
p < 0.001). Regarding global functioning, 20 patients
improved (30.7%) and 45 (69.2%) remained
unchanged. No patients deteriorated. Wilcoxon test
for GAF scores resulted in a large effect size (r was
0.66). In Figure 3 it can be seen that those classified as
recovered or improved according to the RCIs substan-
tially improved in functioning by approximately 15
points.
Differences between those who improved and
those who remained unchanged on global function-
ing were compared by means of chi-square or inde-
pendent samples t-test analyses with regard to patient
characteristics and treatment characteristics. Those
who did not improve on global functioning had
more sessions of NET on average (M = 9.3,
SD = 5.9 vs M = 13.4, SD = 5.4), t(63) = −2.79,
p < 0.01). This implies that a higher trauma load
was associated with less improvement.
3. Discussion
This study provided evidence supporting the feasi-
bility of an outpatient day treatment programme
including NET, even in those patients that before
failed to benefit from other treatments. Changes in
symptoms and global functioning were observed.
Specifically, about 30% of patients showed
a reduction of PTSD symptoms (including those
with full recovery). Enhanced global functioning was
observed in 30% of the patients, which was associated
with fewer NET sessions than those who had a stable
GAF score from T1 to T2. Although, overall,
a minority of the participants improved, those who
actually reliably and clinically improved showed
a considerable alleviation of symptoms or an
improvement in global functioning.
The fact that, in this sample, 78.4% of all patients
completed NET, attests to the feasibility of NET
embedded in an outpatient day treatment pro-
gramme. In a large study on non-response and drop-
out rates in PTSD treatment, it was shown that
dropout rates varied considerably across studies
(Schottenbauer, Glass, Arnkoff, Tendick, & Gray,
2008). The average dropout rate in clinical trials on
PTSD was found to be 20%, although the aggregated
dropout rate of active treatments of PTSD in clinical
trials in a meta-analysis was slightly lower, namely
18.3% (Imel, Laska, Jakupcak, & Simpson, 2013). Yet,
previous studies on NET have reported high treat-
ment completion for NET in comparison to pro-
longed exposure (PE), with mean dropout rates of
5.1% of NET (ranging from 0 − 20%) vs 27.2% in
studies on PE (ranging from 0% to 41%) (Mørkved
et al., 2014). However, only six studies on NET
included samples of refugees resettled in high-
income countries, and dropout rates in these samples
were on average higher than dropout rates of NET in
other samples (Lely, Smid, Jongedijk, Knipscheer, &
Kleber, 2019). The dropout rate of 20.6% in our
naturalistic setting accords with previous studies,
considering that the majority of our sample was diag-
nosed with (chronic) PTSD often classified as
‘extreme’ or ‘severe’ PTSD, and with a history of
unsuccessful treatment prior to the start of the
outpatient day treatment programme.
Of those who dropped out, 60% mentioned reasons
related to current stressors, although no significant
differences were found on the number of current stres-
sors between completers and non-completers. As the
current stressors could be addressed at consultation
hours during the programme, the NET therapist was
indeed able to focus on the NET, as evidenced by our
finding that most therapists did not spend more than
two sessions on other issues than NET. A minority of
those who dropped out (40.0%) specifically felt that the
confrontation with the traumatic memories was too
overwhelming, and were offered non-trauma-focused
treatment. Considering that none of the patients after
NET showed deterioration in terms of PTSD or global
functioning, the use of exposure in the majority of the





T1 Median T2 Median
Total group Improved Unchanged
Figure 3. Change of GAF (y-axis) from T1 to T2 (x-axis).
Table 4. Median of the GAF scores for the total group of
patients with longitudinal GAF data and RCI with regard to
the GAF.
RCI N % T1 Median T2 Median Wilcoxon’s r
Total group 65 100.0 50 55 0.66
Improved 20 30.8 45 60
Unchanged 45 69.2 50 50
Deteriorated 0 0.0
GAF = Global Assessment of Functioning; RCI = Reliable Change index.
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Some differences between completers and non-
completers were found. Although all participants
had already lived in the Netherlands for several
years, the length of stay in the Netherlands was
found significantly higher in the group of completers.
In a systematic review on mental health care utilisa-
tion of refugees, it was found that a longer time of
resettlement was associated with more mental health
care utilisation (Satinsky, Fuhr, Woodward, Sondorp,
& Roberts, 2019). A longer time of resettlement may
be related to more familiarity with mental health care
so that patients will better know what to expect, and
hence facilitating completion.
Completers were also more likely to have
a partner, which suggests that a socially supportive
living environment enhances the acceptability of
trauma-focused treatment in refugees. Several studies
show that perceived lack of social support is a risk
factor for PTSD (Brewin, Andrews, & Valentine,
2000). Perceived social support is also associated
with complex PTSD (Hecker, Huber, Maier, &
Maercker, 2018; Simon, Roberts, Lewis, van
Gelderen, & Bisson, 2019). In a sample of Iraqi refu-
gees more social support was associated with better
acculturation and less mental health complaints
(LeMaster et al., 2018). The current programme
could be modified to support the most vulnerable
group, to further enhance social support which facil-
itates conditions in which a trauma-focussed therapy
can be completed.
Although our findings are encouraging, and effect
sizes are comparable to other studies on NET (Lely
et al., 2019), the number of those reliably improved
or recovered based on the RCI of PTSD symptoms
and global functioning was modest. This may be
explained by several factors. A first point to consider
is the severity of the complaints of the patients. That
is, 70% of the refugees in the study had an overall
severity score in the extreme PTSD range on the
CAPS before treatment. Those who did not improve
on global functioning had more NET sessions on
average, which implies a higher trauma load.
Trauma load is also associated with a higher severity
of PTSD complaints (Kolassa et al., 2010). Hence,
expecting full recovery may not always be realistic.
Indeed, in a meta-analysis of studies on the efficacy of
PTSD treatment in military veterans, a high pre-
treatment PTSD severity was associated with lower
treatment gains (Haagen, Smid, Knipscheer, &
Kleber, 2015). Secondly, the overall number of cur-
rent stressors of the participants was high, despite
several years of resettlement. The impact of current
stressors on mental health has been documented in
several studies (Chu et al., 2013; LeMaster et al., 2018;
Minihan, Liddell, Byrow, Bryant, & Nickerson, 2018;
Schick et al., 2018; Steel et al., 2017; Tinghög et al.,
2017). In the study by Minihan et al. (2018) on
patterns and predictors of PTSD in refugees, living
condition emerged as an important predictor of
PTSD symptoms. In a 3 year follow up study in
a clinical sample of refugees, it was found that reduc-
tion of post-migration living difficulties predicted
changes over time for depression and anxiety, but
not for PTSD (Schick et al., 2018). In our study, it
is unclear in what way current stressors relate to (the
severity and course of) the PTSD complaints and
global functioning or vice versa. Nevertheless, the
number of current stressors in our sample and sever-
ity of the complaints suggests support for the ecolo-
gical model of distress in refugees which postulates
that mental health of refugees is affected not only by
war exposure, but also by current stressors (Miller &
Rasmussen, 2017).
A further notable finding is that the patients who
remained unchanged on PTSD were more likely to
have had a first trauma before the age of 12. A rela-
tionship between childhood adversities and psycho-
pathology later in adulthood has been found in
refugees in at least one study (Opaas & Varvin,
2015). Nevertheless, a meta-analysis of psychological
interventions in patients who have experienced child-
hood adversities showed good results of trauma-
focused interventions (Ehring et al., 2014). In phase 1
of our treatment programme, we incorporate compli-
cating factors often associated with more complex and
often early trauma, such as dissociation, when discuss-
ing emotion regulation (Cloitre et al., 2012). However,
we did not specifically address the debilitating core
cognitions regarding the self, others, and the world,
commonly found in relation to early traumatization.
The moderate effects of NET in those with childhood
trauma may be improved by a person-oriented thera-
peutic stance fostering basic trust and safety or apply-
ing interventions that address dysfunctional/
maladaptive cognitions about self, others and the
world. Notably, long-term interventions may be neces-
sary to achieve symptom remission following child-
hood trauma (Young, Klosko, & Weishaar, 2003).
3.1. Strengths and limitations
A strength of the current study is that it was carried out
in a clinical setting. The naturalistic design demonstrates
how the NET protocol – and possibly other evidence-
based trauma-focused treatments as well – can be suc-
cessfully implemented in clinical practice and conditions
can be met to complete an evidence-based treatment in
a group of severely traumatized refugees.
However, there are several limitations to the current
study. The naturalistic setting only allows us to draw
cautious conclusions on symptom changes and mod-
erators of treatment outcome. The number of NET
sessions was based on the number of traumatic events
(‘stones’) patients mentioned and was not standardized
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across patients. We were not able to examine the rela-
tive contribution of the different components of
the outpatient day treatment programme, such as the
group therapies, to changes in symptoms and global
functioning. A further notable limitation is that no
control group was included.
3.2. Future research
The results of our study are promising and call for
further research on the efficacy of NET in severely
traumatized refugees in a multimodal programme. In
doing so, treatment outcome should preferably be
monitored for a longer period of time. Several studies
found a further decline in symptoms months after
(CBT and/or pharmacotherapeutic) treatment (Böck
Buhmann, Nordentoft, Ekstroem, Carlsson, &
Mortensen, 2018). The efficacy of NET has shown
to be gradual and treatment effects have been found
to continue after termination of treatment (Palic &
Elklit, 2011). Therefore, a follow-up assessment of the
patients participating in the outpatient day treatment
programme is needed.
In a larger sample, it would be important to
examine what factors moderate treatment response
and how the severity of the complaints interacts
with current stressors using multi-composite mod-
erators. The relative contribution of single modera-
tors is found to be limited and diffuse. In several
studies, different moderators were found, such as
gender, age, or employment status, whereas other
studies found legal status, resettlement variables or
post-migration stressors related to mental health
outcome or treatment response (Li, Liddell, &
Nickerson, 2016; Sonne et al., 2016; Stammel
et al., 2017; Stenmark, Catani, Neuner, Elbert, &
Holen, 2013; Stenmark, Guzey, Elbert, & Holen,
2014; Whitsett & Sherman, 2017). Predicting treat-
ment outcome may require multi-composite mod-
erators (Cloitre, Petkova, Su, & Weiss, 2016;
Smagula et al., 2016; Wallace, Frank, & Kraemer,
2013). This may be helpful in gaining insight in
who will benefit from what type of intervention.
4. Conclusions
NET embedded in an outpatient day treatment pro-
gramme is feasible and facilitates the chance of com-
pletion of trauma-focused therapy. The current study
shows that even in those patients that have a history
of unsuccessful treatment offering a trauma-focussed
therapy embedded in an outpatient day treatment
programme can be worthwhile. In those who
improved, a substantial decline in symptoms and
better functioning was observed. Our findings suggest
that a socially supportive living environment
enhances the acceptability of trauma-focused treat-
ment in refugees.
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